ENHYPEN Resumes ‘BLOOD SAGA’ World Tour in Busan with First Performance of New Song ‘Bloody Paradise’

ENHYPEN (Jeongwon, Jay, Jake, Sunghoon, Sunoo, Ni-ki) will hold the “ENHYPEN WORLD TOUR ‘BLOOD SAGA’” at the Busan Sasang Indoor Gymnasium on August 8 and 9. All tickets were sold out during the early pre-sale phase for fans, demonstrating the group’s immense popularity.

The Busan shows are part of the lead-up to their Comeback with the release of their eighth mini-album, “THE SIN : BLISS,” on August 21. Moving away from traditional fan showcase formats, ENHYPEN will meet their fans in a concert setting to discuss the meaning behind the new album. These performances are particularly special because they mark the first time the title track, “Bloody Paradise,” will be performed live.

“Bloody Paradise” is a song that tells the story of lovers who focus solely on each other even in times of crisis. The Busan concerts will also feature storytelling and stage designs based on the vampire universe, which is central to “BLOOD SAGA.” The musical-inspired structure and stage designs tailored to the concept are set to enhance audience immersion alongside the performances.
ENHYPEN’s Blood Saga world tour began at the KSPO DOME in Seoul last May. Since then, the tour has included 12 performances across 8 cities in North and South America, attracting approximately 193,000 fans. The Busan shows represent the continuation of this successful tour in Asia following its conclusion in North and South America.

Further international performances are also planned. A show at La Défense Arena in Paris is scheduled, with general ticket sales starting at 10 a.m. on April 24 according to French time. In the United States, general ticket purchases began at 4 p.m. on the same day.

Ticket prices vary by region. Tickets in the U.S. are priced between $130 and $209.40. Tickets can also be purchased through online resale platforms such as Vivid Seats, StubHub, and SeatGeek.
발행·편집 책임: 국기봉 · KPOP Signal editorialThis article was written with AI from verified source material and passed automated checks before publication. It may contain factual errors. AI disclosure · Request a correction
Comments (0)
No comments yet — be the first to start the conversation.